TNOA Journal of Ophthalmic Science and Research

: 2022  |  Volume : 60  |  Issue : 2  |  Page : 207--209

Orbital Mucormycosis in Covid- 19: A Case Presentation

Rajakannan Durairaj 
 Department of Ophthalmology, ESICPGIMSR, Chennai, Tamil Nadu, India

Correspondence Address:
Rajakannan Durairaj
191, 100 Feet Bypass Road, Vijaya Nagar, Velachery - 42, Chennai, Tamil Nadu

A 53–year-old male presented with a left eye swelling, proptosis, loss of vision, and complete ophthalmoplegia. Orbital mucormycosis is leading to the diagnosis of COVID 19,the patient was treated for the same. The author wants to insist that Orbital mucormycosis can develop in COVID-19 patients with comorbidities and patients under treatment with corticosteroidsfor COVID-19, which requires prompt diagnosis and management.

How to cite this article:
Durairaj R. Orbital Mucormycosis in Covid- 19: A Case Presentation.TNOA J Ophthalmic Sci Res 2022;60:207-209

How to cite this URL:
Durairaj R. Orbital Mucormycosis in Covid- 19: A Case Presentation. TNOA J Ophthalmic Sci Res [serial online] 2022 [cited 2022 Sep 26 ];60:207-209
Available from:;year=2022;volume=60;issue=2;spage=207;epage=209;aulast=Durairaj;type=0